Cargando…

Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience

PURPOSE/OBJECTIVES: High-intensity focused ultrasound (HIFU) remains investigational as primary treatment for localized prostate cancer but is sometimes offered to select patients. At HIFU failure, data guiding salvage treatment is limited to small retrospective series with short follow-up. We evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Lalla, Vanessa, Elakshar, Sara, Anidjar, Maurice, Tolba, Marwan, Hassan, Toufic, Bahoric, Boris, McPherson, Victor, Probst, Stephan, Niazi, Tamim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669274/
https://www.ncbi.nlm.nih.gov/pubmed/36408146
http://dx.doi.org/10.3389/fonc.2022.1028858
_version_ 1784832064264077312
author Di Lalla, Vanessa
Elakshar, Sara
Anidjar, Maurice
Tolba, Marwan
Hassan, Toufic
Bahoric, Boris
McPherson, Victor
Probst, Stephan
Niazi, Tamim
author_facet Di Lalla, Vanessa
Elakshar, Sara
Anidjar, Maurice
Tolba, Marwan
Hassan, Toufic
Bahoric, Boris
McPherson, Victor
Probst, Stephan
Niazi, Tamim
author_sort Di Lalla, Vanessa
collection PubMed
description PURPOSE/OBJECTIVES: High-intensity focused ultrasound (HIFU) remains investigational as primary treatment for localized prostate cancer but is sometimes offered to select patients. At HIFU failure, data guiding salvage treatment is limited to small retrospective series with short follow-up. We evaluated our institutional experience using salvage radiation therapy (SRT) after HIFU failure. MATERIALS/METHODS: We conducted a retrospective analysis of patients with local failure post-HIFU who received salvage image-guided external beam radiation therapy (EBRT) delivered via intensity-modulated radiotherapy (IMRT). Our primary endpoint was biochemical failure-free survival (bFFS) defined as prostate-specific antigen (PSA) nadir + 2 ng/mL. Secondary endpoints included metastasis-free survival (MFS) and overall survival (OS). Endpoints were evaluated using Kaplan-Meier analysis. RESULTS: From 2013 to 2018, 12 out of 96 patients treated with primary HIFU received SRT via conventional or moderate hypofractionation. Median time from HIFU to SRT was 13.5 months. Seven patients had stage migration to high-risk disease at the time of SRT. Mean PSA prior to SRT was 8.2ug/L and mean nadir post-SRT was 1.2ug/L. Acute International Prostate Symptom Score (IPSS) as well as International Index of Erectile Dysfunction (IIEF) scores were similar to baseline (p = 0.5 and 0.1, respectively). Late toxicities were comparable to those reported after primary EBRT for localized prostate cancer. At a median follow-up of 46 months, the OS was 100%. The 5-year bFFS and MFS were both 83.3%. CONCLUSIONS: To our knowledge, we report one of the largest series on contemporary SRT post HIFU failure. We show that SRT is feasible, effective and carries no additional acute or delayed toxicity.
format Online
Article
Text
id pubmed-9669274
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96692742022-11-18 Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience Di Lalla, Vanessa Elakshar, Sara Anidjar, Maurice Tolba, Marwan Hassan, Toufic Bahoric, Boris McPherson, Victor Probst, Stephan Niazi, Tamim Front Oncol Oncology PURPOSE/OBJECTIVES: High-intensity focused ultrasound (HIFU) remains investigational as primary treatment for localized prostate cancer but is sometimes offered to select patients. At HIFU failure, data guiding salvage treatment is limited to small retrospective series with short follow-up. We evaluated our institutional experience using salvage radiation therapy (SRT) after HIFU failure. MATERIALS/METHODS: We conducted a retrospective analysis of patients with local failure post-HIFU who received salvage image-guided external beam radiation therapy (EBRT) delivered via intensity-modulated radiotherapy (IMRT). Our primary endpoint was biochemical failure-free survival (bFFS) defined as prostate-specific antigen (PSA) nadir + 2 ng/mL. Secondary endpoints included metastasis-free survival (MFS) and overall survival (OS). Endpoints were evaluated using Kaplan-Meier analysis. RESULTS: From 2013 to 2018, 12 out of 96 patients treated with primary HIFU received SRT via conventional or moderate hypofractionation. Median time from HIFU to SRT was 13.5 months. Seven patients had stage migration to high-risk disease at the time of SRT. Mean PSA prior to SRT was 8.2ug/L and mean nadir post-SRT was 1.2ug/L. Acute International Prostate Symptom Score (IPSS) as well as International Index of Erectile Dysfunction (IIEF) scores were similar to baseline (p = 0.5 and 0.1, respectively). Late toxicities were comparable to those reported after primary EBRT for localized prostate cancer. At a median follow-up of 46 months, the OS was 100%. The 5-year bFFS and MFS were both 83.3%. CONCLUSIONS: To our knowledge, we report one of the largest series on contemporary SRT post HIFU failure. We show that SRT is feasible, effective and carries no additional acute or delayed toxicity. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9669274/ /pubmed/36408146 http://dx.doi.org/10.3389/fonc.2022.1028858 Text en Copyright © 2022 Di Lalla, Elakshar, Anidjar, Tolba, Hassan, Bahoric, McPherson, Probst and Niazi https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Di Lalla, Vanessa
Elakshar, Sara
Anidjar, Maurice
Tolba, Marwan
Hassan, Toufic
Bahoric, Boris
McPherson, Victor
Probst, Stephan
Niazi, Tamim
Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title_full Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title_fullStr Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title_full_unstemmed Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title_short Salvage external beam radiotherapy after HIFU failure in localized prostate cancer: A single institution experience
title_sort salvage external beam radiotherapy after hifu failure in localized prostate cancer: a single institution experience
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669274/
https://www.ncbi.nlm.nih.gov/pubmed/36408146
http://dx.doi.org/10.3389/fonc.2022.1028858
work_keys_str_mv AT dilallavanessa salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT elaksharsara salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT anidjarmaurice salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT tolbamarwan salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT hassantoufic salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT bahoricboris salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT mcphersonvictor salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT probststephan salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience
AT niazitamim salvageexternalbeamradiotherapyafterhifufailureinlocalizedprostatecancerasingleinstitutionexperience